The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals

The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals: A Retrospective Study and Review With Clinical Implications

This study collected real-world evidence to better understand and define the relative bioavailability ratio between compounded rapamycin and generic rapamycin, with a specific focus on relative efficacy in increasing rapamycin levels in the blood (blood rapamycin levels).

Inclusion Criteria:

• Receive AgelessRx's standard Rapamycin treatment protocol
• Opted to complete at least 1 blood draw at their local Quest Lab

Exclusion Criteria:

• Not approved for current AgelessRx standard Rapamycin treatment
• History of uncontrolled disease
• Unable to complete at least 1 blood draw at their local Quest Lab